Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial
Titel:
Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial
Auteur:
Choueiri, Toni K Larkin, James Oya, Mototsugu Thistlethwaite, Fiona Martignoni, Marcella Nathan, Paul Powles, Thomas McDermott, David Robbins, Paul B Chism, David D Cho, Daniel Atkins, Michael B Gordon, Michael S Gupta, Sumati Uemura, Hirotsugu Tomita, Yoshihiko Compagnoni, Anna Fowst, Camilla di Pietro, Alessandra Rini, Brian I